Rantac | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

167 results for “Rantac”

Trials

View all 66 →

An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Podocyte Diseases

30 participants · First posted Oct 30, 2024

PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer

51 participants · First posted Jul 26, 2004

Vantas Implant Retrieval Study

12 participants · First posted Nov 13, 2009

Drugs

View all 35 →

NNY-RANTES

RanTop(Orgenesis)

PSC-RANTES

Organizations

View all 39 →

RANJAN DOHIL

India

Yantai Yuhuangding Hospital

China

Pantec Biosolutions AG

Liechtenstein

News

View all 27 →

Torrent Pharma Advances $2.4 Billion Acquisition of JB Chemicals in Major Industry Consolidation Move

GSK Raises 2031 Revenue Target to £40 Billion Despite Zantac Impact on Profits

Cobenfy Shows Cognitive Benefits in Schizophrenia Patients with CANTAB Assessment

Page 1 of 17